Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Raal

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Annals of Medicine|August 17, 2024
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a referenceAlpo Vuorio, Bruce Budowle, Frederick Raal, et al.
Atherosclerosis|February 4, 2021
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatmentAlpo Vuorio, Frederick Raal, Markku Kaste, et al.
Frontiers in Cardiovascular Medicine|October 2, 2023
Wildfire smoke exposure and cardiovascular disease-should statins be recommended to prevent cardiovascular events?Alpo Vuorio, Bruce Budowle, Frederick Raal, et al.
Journal of Clinical Lipidology|June 8, 2021
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19Alpo Vuorio, Frederick Raal, Reinhard Klingel, et al.
European Journal of Preventive Cardiology|September 20, 2017
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysisRobert Leipold, Frederick Raal, Jack Ishak, et al.
Cardiology and Therapy|November 17, 2021
Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global ChallengeAlpo Vuorio, Petri T Kovanen, Raul D Santos, et al.
Metabolic Syndrome and Related Disorders|July 24, 2012
High-dose statin therapy does not induce insulin resistance in patients with familial hypercholesterolemiaVanessa Panz, Andrew Immelman, Janice Paiker, et al.
Frontiers in Pharmacology|June 1, 2022
Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial HypercholesterolemiaAlpo Vuorio, Frederick Raal, Petra Ijäs, et al.
International Journal of General Medicine|November 30, 2016
Multi-ethnic differences in HbA<sub>1c</sub>, blood pressure, and low-density-lipid cholesterol control among South Africans living with type 2 diabetes, after a 4-year follow-upYacob Pinchevsky, Varada J Shukla, Neil Butkow, et al.
International Journal of General Medicine|October 17, 2018
Quality of care delivered to type 2 diabetes mellitus patients in public and private sector facilities in Johannesburg, South AfricaYacob Pinchevsky, Frederick Raal, Neil Butkow, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Annals of Medicine|August 17, 2024
Statins for the prevention of cardiovascular events associated with avian influenza: the COVID-19 pandemic as a referenceAlpo Vuorio, Bruce Budowle, Frederick Raal, et al.
Atherosclerosis|February 4, 2021
Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatmentAlpo Vuorio, Frederick Raal, Markku Kaste, et al.
Frontiers in Cardiovascular Medicine|October 2, 2023
Wildfire smoke exposure and cardiovascular disease-should statins be recommended to prevent cardiovascular events?Alpo Vuorio, Bruce Budowle, Frederick Raal, et al.
Journal of Clinical Lipidology|June 8, 2021
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19Alpo Vuorio, Frederick Raal, Reinhard Klingel, et al.
European Journal of Preventive Cardiology|September 20, 2017
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysisRobert Leipold, Frederick Raal, Jack Ishak, et al.
Cardiology and Therapy|November 17, 2021
Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global ChallengeAlpo Vuorio, Petri T Kovanen, Raul D Santos, et al.
Metabolic Syndrome and Related Disorders|July 24, 2012
High-dose statin therapy does not induce insulin resistance in patients with familial hypercholesterolemiaVanessa Panz, Andrew Immelman, Janice Paiker, et al.
Frontiers in Pharmacology|June 1, 2022
Long-Term Cardiovascular and Cerebrovascular Challenges Posed by COVID-19 in Patients With Familial HypercholesterolemiaAlpo Vuorio, Frederick Raal, Petra Ijäs, et al.
International Journal of General Medicine|November 30, 2016
Multi-ethnic differences in HbA<sub>1c</sub>, blood pressure, and low-density-lipid cholesterol control among South Africans living with type 2 diabetes, after a 4-year follow-upYacob Pinchevsky, Varada J Shukla, Neil Butkow, et al.
International Journal of General Medicine|October 17, 2018
Quality of care delivered to type 2 diabetes mellitus patients in public and private sector facilities in Johannesburg, South AfricaYacob Pinchevsky, Frederick Raal, Neil Butkow, et al.
Pageof 5